AQUESTIVE THERAPEUTICS INC (AQST) Stock Cash Flow
NASDAQ:AQST - Nasdaq - US03843E1047 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -54.24M | -44.14M | -7.87M | -54.41M | -70.54M | |||
| Depreciation Amortization | 650.00K | 718.00K | 1.34M | 2.39M | 2.96M | |||
| Change In Working Capital | -12.90M | -9.96M | -5.34M | 32.01M | -1.73M | |||
| Interest Paid | 7.62M | 7.10M | 4.60M | 6.44M | 6.44M | |||
| Taxes Paid | N/A | 305.00K | N/A | N/A | N/A | |||
| Other non cash items | 17.71M | 17.62M | 5.49M | 10.23M | 36.33M | |||
| OPERATING CASH FLOW | -48.77M | -35.76M | -6.38M | -9.79M | -32.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -265.00K | -159.00K | -995.00K | -2.52M | -910.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -265.00K | -159.00K | -995.00K | -2.52M | -910.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -23.00K | -22.49M | -2.03M | 0.00 | |||
| Stock Issued/Repurchased | 23.44M | 84.72M | 17.26M | 13.59M | 30.12M | |||
| Other Financing Activity | -927.00K | -1.11M | 9.20M | 0.00 | -10.00K | |||
| FINANCING CASH FLOW | 22.50M | 83.59M | 3.97M | 11.56M | 30.11M | |||
| CHANGE IN CASH | -26.54M | 47.67M | -3.40M | -750.00K | -3.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.77M | -35.76M | -6.38M | -9.79M | -32.98M | |||
| Capital Expenditure | -265.00K | -159.00K | -995.00K | -2.52M | -910.00K | |||
| FREE CASH FLOW | -49.04M | -35.92M | -7.38M | -12.31M | -33.89M | |||
All data in USD